Opportunity Information: Apply for CDC RFA GH15 1583
Apply for CDC RFA GH15 1583
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services in Manzini Region, and Provide Central Level Technical Assistance to the National Tuberculosis" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Sep 23, 2014 and posted on Aug 26, 2014.
- Applicants must submit their applications by Oct 16, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,200,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $4,200,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants that can apply for this FOA are listed below Government Organizations National Ministries of Health State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) Political subdivisions of States (in consultation with States) Non government Organizations American Indian/Alaska native tribally designated organizations Alaska Native health corporations Tribal epidemiology centers Urban Indian health organizations Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Research institutions (that will perform activities deemed as non research) Colleges and Universities Community based organizations Faith based organizations For profit organizations (other than small business) Hospitals Small, minority, and women owned businesses All Other eligible organizations PEPFAR Local Partner definition To be considered eligible as a local partner under this Funding Opportunity Announcement, the applicant must submit supporting documentation demonstrating how their organization meets one of the three criteria listed below under the PEPFAR Local Partner definition. The supporting documentation must be included in the Appendices of the application and must be labeled as Eligibility Documentation for PEPFAR Local Partner Definition. Applicants that do not provide and/or label the supporting documentation required to meet the PEPFAR Local Partner definition above will not be considered eligible for review. Under PEPFAR, a local partner may be an individual or sole proprietorship, an entity, or a joint venture or other arrangement. However, to be considered a local partner in a given country served by PEPFAR, the partner must meet the criteria under paragraph (1), (2), or (3) below (1) an individual must be a citizen or lawfully admitted permanent resident of and have his/her principal place of business in the country served by the PEPFAR program with which the individual is or may become involved, and a sole proprietorship must be owned by such an individual
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC cooperative agreement (CDC RFA GH15-1583) focuses on strengthening Swaziland's ability to deliver sustainable, high-quality, and fully integrated HIV and TB clinical services, with a particular emphasis on Manzini Region while also providing central-level technical assistance to the National Tuberculosis program. The opportunity is framed around the reality that Swaziland faces one of the most intense HIV/TB dual epidemics globally, with adult HIV prevalence around 31 percent among people ages 18 to 49, an estimated adult HIV incidence as high as 2.4 annually, and an extremely high TB incidence (about 1,380 per 100,000). The burden is compounded by the fact that roughly three-quarters to four-fifths of TB patients are also living with HIV, and HIV prevalence among pregnant women is reported at about 41 percent. With thousands of TB cases expected annually, the grant seeks to close persistent service delivery gaps and push the country closer to universal coverage under updated WHO 2013 recommendations.
At its core, the grant is about improving the full clinical continuum for HIV and TB: testing, linkage to care, initiation of treatment, ongoing retention, and long-term outcomes. The CDC is looking for work that makes services more seamless and comprehensive, and that integrates HIV and TB care within existing health system structures rather than relying on parallel, stand-alone programs. A major theme is quality assurance and consistent clinical standards across facilities, so that patients receive reliable, guideline-based care regardless of where they enter the system. Alongside that, the opportunity emphasizes building sustainable stewardship capacity within the Ministry of Health at national, regional, and facility levels, meaning stronger management, supervision, monitoring, and problem-solving capabilities that can endure beyond donor funding.
The description highlights that Swaziland has already made real progress scaling up HIV and TB services, including key TB/HIV collaborative activities such as intensified TB case finding (ICF), isoniazid preventive therapy (IPT), and TB infection prevention and control (IPC). However, the grant is driven by the idea that progress is uneven and that missed opportunities remain common, especially for populations that often fall through the cracks. The CDC points specifically to gaps in reaching children and adolescents with HIV services, improving access for key populations, increasing ART coverage among pregnant women and among people diagnosed with TB, and using scarce resources more efficiently. In practical terms, that implies a strong interest in approaches that improve case finding, speed up linkage and treatment initiation, reduce loss to follow-up, and ensure that pregnant women and TB patients who are eligible for ART actually start it quickly and stay on it.
Geographically, the award targets Manzini Region for strengthening local capacity to deliver these integrated HIV/TB clinical services at universal coverage levels with strong quality assurance. At the same time, it includes a national component: providing central-level technical assistance to the National Tuberculosis program. That national technical assistance likely involves strengthening policies and guidelines, improving planning and coordination, reinforcing surveillance and program monitoring, and supporting consistent implementation of TB/HIV collaborative activities across the country. The emphasis on sustainability suggests the recipient would be expected to mentor and train Ministry of Health counterparts, strengthen routine systems (rather than create new ones that only function with external support), and institutionalize quality improvement and supportive supervision practices.
From a funding standpoint, the opportunity was posted in late August 2014 and ultimately closed in mid-October 2014, with an estimated total funding amount of $4.2 million and an award ceiling of $4.2 million. The CDC anticipated making one award, and the funding instrument is a cooperative agreement, which generally means the CDC expects substantial programmatic involvement beyond what is typical in a standard grant, such as close collaboration on technical direction, monitoring expectations, and performance improvement. The CFDA number is 93.067 (Global AIDS), and there is no cost sharing or matching requirement.
Eligibility is broad and includes government entities, ministries of health, state and local governments and their agents, tribal governments and tribal health entities, nonprofits (with or without 501(c)(3)), colleges and universities, research institutions conducting non-research programmatic work, community-based and faith-based organizations, hospitals, and certain for-profit organizations. A key condition is the PEPFAR local partner requirement: applicants seeking to be treated as local partners must provide supporting documentation in the application appendices showing they meet one of the defined criteria. The announcement is administered by the Centers for Disease Control and Prevention, and assistance for accessing the full announcement was directed to CDC's Procurement and Grants Office Technical Information Management Section.
Frequently Asked Questions (FAQs)
What is the purpose of CDC RFA GH15-1583?
This CDC cooperative agreement focuses on strengthening Swaziland's ability to deliver sustainable, high-quality, and fully integrated HIV and TB clinical services. It emphasizes closing persistent service delivery gaps and moving the country closer to universal coverage under updated WHO 2013 recommendations.
Which diseases and services does this opportunity focus on?
The opportunity targets HIV and tuberculosis (TB) and is centered on improving the full clinical continuum: testing, linkage to care, initiation of treatment, retention in care, and long-term outcomes. A key expectation is better integration of HIV and TB services within existing health system structures.
Where will the work be implemented?
The award targets Manzini Region as the primary geographic focus for strengthening local capacity to deliver integrated HIV/TB clinical services with strong quality assurance. It also includes a national component that provides central-level technical assistance to the National Tuberculosis program.
What does "integrated HIV and TB clinical services" mean in this announcement?
It refers to delivering HIV and TB care in a seamless and comprehensive way, integrated within existing health system structures rather than through parallel, stand-alone programs. The intent is that patients receive coordinated services and consistent, guideline-based care regardless of where they enter the system.
Why is this funding opportunity needed in Swaziland?
The announcement is framed around Swaziland facing one of the most intense HIV/TB dual epidemics globally, including very high adult HIV prevalence, high estimated adult HIV incidence, and extremely high TB incidence. The burden is compounded by the fact that roughly three-quarters to four-fifths of TB patients are also living with HIV, and HIV prevalence among pregnant women is reported at about 41 percent.
What kinds of gaps is the CDC trying to address through this award?
The description highlights uneven progress and missed opportunities, especially for populations that often fall through the cracks. Specific gaps mentioned include reaching children and adolescents with HIV services, improving access for key populations, increasing ART coverage among pregnant women and among people diagnosed with TB, and using scarce resources more efficiently.
What program approaches does the announcement appear to prioritize?
Based on the description, priorities include improving case finding, speeding up linkage to care and treatment initiation, reducing loss to follow-up, and ensuring eligible pregnant women and TB patients start ART quickly and remain on treatment. There is also a strong emphasis on quality assurance, consistent clinical standards across facilities, and strengthening Ministry of Health stewardship and management capacity.
Does the opportunity include TB/HIV collaborative activities?
Yes. The announcement notes progress in key TB/HIV collaborative activities such as intensified TB case finding (ICF), isoniazid preventive therapy (IPT), and TB infection prevention and control (IPC), and it positions the award as a way to strengthen and improve consistent implementation of these types of activities.
What is meant by "quality assurance" and consistent clinical standards in this grant?
A major theme is ensuring patients receive reliable, guideline-based care across facilities. The opportunity emphasizes consistent clinical standards and quality assurance so that care is dependable regardless of where a patient enters the system.
What does "sustainability" mean in the context of this cooperative agreement?
Sustainability is described as building stewardship capacity within the Ministry of Health at national, regional, and facility levels, including stronger management, supervision, monitoring, and problem-solving capabilities that can endure beyond donor funding. The description also suggests strengthening routine systems rather than creating new, parallel systems that only function with external support.
What is the national-level component of the award?
In addition to work in Manzini Region, the award includes providing central-level technical assistance to the National Tuberculosis program. The description indicates this likely includes strengthening policies and guidelines, improving planning and coordination, reinforcing surveillance and program monitoring, and supporting consistent implementation of TB/HIV collaborative activities across the country.
What is the funding instrument for this opportunity?
The funding instrument is a cooperative agreement. This generally means the CDC expects substantial programmatic involvement, such as close collaboration on technical direction, monitoring expectations, and performance improvement.
How much funding is available and what is the award ceiling?
The estimated total funding amount is $4.2 million, and the award ceiling is $4.2 million.
How many awards did the CDC anticipate making?
The CDC anticipated making one award.
When was the opportunity posted and when did it close?
The opportunity was posted in late August 2014 and closed in mid-October 2014.
What is the CFDA number for this opportunity?
The CFDA number listed is 93.067 (Global AIDS).
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes government entities, ministries of health, state and local governments and their agents, tribal governments and tribal health entities, nonprofits (with or without 501(c)(3)), colleges and universities, research institutions conducting non-research programmatic work, community-based and faith-based organizations, hospitals, and certain for-profit organizations.
Are for-profit organizations eligible?
Yes. The eligibility list includes certain for-profit organizations.
Are research institutions eligible?
Yes. The announcement includes research institutions, specifically those conducting non-research programmatic work.
What is the PEPFAR local partner requirement mentioned in the announcement?
Applicants seeking to be treated as local partners must provide supporting documentation in the application appendices showing they meet one of the defined criteria. The opportunity notes this as a key condition for local partner treatment.
Which agency is administering this funding opportunity?
The announcement is administered by the Centers for Disease Control and Prevention (CDC).
Where was support offered for accessing the full announcement?
Assistance for accessing the full announcement was directed to the CDC's Procurement and Grants Office Technical Information Management Section.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: San Joaquin River Restoration Program Seepage Projects
Previous opportunity: Capacity Building through Training and Mentoring for Treatment, Care and Support, Including PMTCT, TB/HIV, Laboratory, Informatics, and Cervical Cancer in Botswana under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1583
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1583) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region, Apply for CDC RFA GH15 1582 Funding Number: CDC RFA GH15 1582 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,200,000 |
| Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1581 Funding Number: CDC RFA GH15 1581 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,100,000 |
| Implementing an Electronic Monitoring and Reporting System in the Republic of Rwanda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1569 Funding Number: CDC RFA GH15 1569 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $310,000 |
| Monitoring and Evaluation Technical Support (METS) to Strengthen Monitoring and Evaluation, Disease Surveillance and the Capabilities of District Health Teams in the Republic of Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1611 Funding Number: CDC RFA GH15 1611 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,400,000 |
| Strengthening Regional and Community Health Systems through Support for Field Epidemiology in Tanzania under the Presidens Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1585 Funding Number: CDC RFA GH15 1585 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $450,000 |
| Technical Assistance for Strengthening National Laboratory Systems in Uganda under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1593 Funding Number: CDC RFA GH15 1593 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Strengthening the Capacity to Scale up HIV Prevention, Care and Treatment Programs in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1572 Funding Number: CDC RFA GH15 1572 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,800,000 |
| Support to Increasing Access to Voluntary Medical Male Circumcision (VMMC) Services in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1555 Funding Number: CDC RFA GH15 1555 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Increase Access to Comprehensive HIV/AIDS Prevention, Care and Treatment Services in the Democratic Republic of Congo under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1521 Funding Number: CDC RFA GH15 1521 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| USAID/Uganda Regional Health Integration to Enhance Services in East Central Uganda Apply for RFA 617 14 000013 Funding Number: RFA 617 14 000013 Agency: Uganda USAID Kampala Category: Health Funding Amount: $57,000,000 |
| Strengthen Uganda Ministry of Health Capacity to Execute its Essential Public Health Functions through Provision of Technical Assistance, Public Health Workforce Development and Institutional Capacity Building in the Republic of Uganda under PEPFAR Apply for CDC RFA GH15 1592 Funding Number: CDC RFA GH15 1592 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| USAID/Ghana WASH for Health Apply for RFA 641 14 000007 Funding Number: RFA 641 14 000007 Agency: Ghana USAID Accra Category: Health Funding Amount: $18,700,000 |
| Approaches to Eliminate HIV and Opportunistic Pathogens from Oral Reservoirs (R01) Apply for RFA DE 15 003 Funding Number: RFA DE 15 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening High Quality Laboratory Services Scale up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1551 Funding Number: CDC RFA GH15 1551 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Serious STEM Games for Pre College and Informal Science Education Audiences (SBIR) (R43/R44) Apply for PAR 14 325 Funding Number: PAR 14 325 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Serious STEM Games for Pre College and Informal Science Education Audiences (STTR) (R41/R42) Apply for PAR 14 326 Funding Number: PAR 14 326 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1594 Funding Number: CDC RFA GH15 1594 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Capacity Building through Training/Mentoring for Treatment, Care and Support including Preventing Mother to Child Transmission (PMTCT) TB/HIV Health System Strengthening and Voluntary Medical Male Circumcision in Zambia under the Presidents Emergency Apply for CDC RFA GH15 1597 Funding Number: CDC RFA GH15 1597 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Enhancing the Government of Indias Capacity through PEPFAR to Scale Up and Improve Comprehensive HIV Service Package Quality for People Who Inject Drugs under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1542 Funding Number: CDC RFA GH15 1542 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,800,000 |
| Administrative Supplements for U.S. Brazil Biomedical Collaborative Research Apply for PA 14 328 Funding Number: PA 14 328 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1583", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.